3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Lymphoid
1
Dermatologic
1
Conditions
Neoplasms
6
Colorectal Neoplasms
3
Stomach Neoplasms
2
Lung Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
Uveal Melanoma
1
Skin Neoplasms
1
Sezary Syndrome
1
Retroviridae Infections
1
Recurrence
1
Prostatic Neoplasms
1
Pancreatic cancer, adult
1
Ovarian Neoplasms
1
Mycosis Fungoides
1
Malnutrition
1
Lymphoma, T-Cell, Cutaneous
1
Lymphoma
1
Glioblastoma
1
Esophageal Neoplasms
1
Colorectal Neoplasms, Hereditary Nonpolyposis
1
Colonic Neoplasms
1
Carcinoma, Hepatocellular
1
Barrett Esophagus
1
Interventions
pembrolizumab
8
Nivolumab
6
Ipilimumab
6
cemiplimab
4
aldesleukin
3
Interleukin-2
3
Blood Specimen Collection
3
fludarabine
2
Specimen Handling
2
HhAntag691
2
Cyclophosphamide
2
Biopsy
2
trametinib
1
spartalizumab
1
sonidegib
1
pertuzumab
1
lifileucel
1
four-arm poly(ethylene oxide)-b-poly(2-(diethylamino)ethyl methacrylate)
1
fludarabine phosphate
1
dabrafenib
1
brodalumab
1
atezolizumab
1
Vitamin A
1
Trastuzumab
1
Tissue Banks
1
Surgical Procedures, Operative
1
Standard of Care
1
Second Harmonic Generation Microscopy
1
Resistance Training
1
Red Light
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Skin Neoplasms
×
Hematologic Tests
×
Clear all
NCT04904146
2025-03-10
BIO-MUSE
Lund University Hospital
Recruiting
120 enrolled